本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Avalo Therapeutics Inc

16.12
-1.0600-6.17%
盤後16.120.00000.00%19:30 EDT
成交量:252.55萬
成交額:4,155.14萬
市值:8.65億
市盈率:-3.66
高:18.14
開:17.42
低:16.02
收:17.18
52周最高:24.27
52周最低:9.54
股本:5,363.00萬
流通股本:4,014.95萬
量比:3.39
換手率:6.29%
股息:- -
股息率:- -
每股收益(TTM):-4.4100
每股收益(LYR):-5.8400
淨資產收益率:-36.27%
總資產收益率:-18.50%
市淨率:1.93
市盈率(LYR):-2.76

資料載入中...

2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/23

重要事件披露

Form 8-K - Current report
2026/03/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

SEC問詢函

Form CORRESP - Correspondence